This company seems to have been delisted
Reason: Merged with Tectonic Therapeutic
Source: https://investors.tectonictx.com/news-releases/news-release-details/tectonic-therapeutic-announces-closing-merger-avrobio-well
Reason: Merged with Tectonic Therapeutic
Source: https://investors.tectonictx.com/news-releases/news-release-details/tectonic-therapeutic-announces-closing-merger-avrobio-well
AVROBIO
AVRO
HK$10.86
Share price
-1.41%
Change (1 day)
-90.83%
Change (1 year)
Categories
Earnings for AVROBIO (AVRO)
Earnings in 2024 (TTM): HK$0.23 Billion
According to AVROBIO's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of HK$93.35 Million, an increase over its 2022 earnings that were of -HK$0.82 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for AVROBIO from 2017 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024 (TTM)  | HK$0.23 B | 146.7% |
| 2023 | HK$93.35 M | -111.41% |
| 2022 | -HK$0.82 Billion | -11.29% |
| 2021 | -HK$0.93 Billion | -1.15% |
| 2020 | -HK$0.94 Billion | 58.59% |
| 2019 | -HK$0.59 Billion | 63.94% |
| 2018 | -HK$0.36 Billion | 151.51% |
| 2017 | -HK$0.15 Billion |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -HK$1.11 Billion | -587.50% | 🇺🇸 USA |